BI 411034

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 411034, covering 2014-04-17 to 2014-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Tolerability and Pharmacokinetic of BI 411034 [Phase 1]